Joseph Vento, MD, MS
@JVentoMD
Followers
373
Following
294
Media
14
Statuses
82
Oncologist @UTSWMedCenter @Parkland | Cancer Informatics and GU Malignancies | Husband, Dad | Fan of Bow Tie Fri | Views My Own
Joined January 2022
RT @rmistry91: As much as #ASCO25 is about building new connections, it’s also about fostering old ones #NoNewFriends . @JVentoMD @catherin….
0
3
0
RT @TiansterZhang: Of pts on #PDIGREE, 23% had IMDC poor risk, with fewer (21%) treated in step 2. Simillarly, 27.7% had bone mets, with fe….
0
10
0
RT @TheFellowOnCall: 🚨Hot off the press: A simultaneous publication in @JCOOP_ASCO alongside @vpatelmd’s presentation highlighting the 1st….
0
17
0
RT @TiansterZhang: Congratulations to all @ASCO @ConquerCancerFd #CDA & #YIA recipients! . @CarlosArteagaMD @suzanneconzenmd @andyzwang & I….
0
9
0
RT @JBrugarolas: Congratulations to our one of a kind #AI #kidneycancer @KCPUTSW @UTSWcomps team with David Hein, Alana Christie, Bing Xie,….
0
11
0
Neat experience getting to speak about non-clear cell RCC subtypes after authoring a review with stellar UTSW mentors @QianJanieQin @TiansterZhang @PayalKapur5 @JBrugarolas @HHammersMD . Review link:
@JVentoMD presnting the management complexity of the heterogeneous Non-Clear-Cell RCC. @OncLive @OncLiveSOSS @utswcancer @UTSWMedCenter
2
2
26
RT @BRoseMDMPH: 📢 Informatics will lead oncology into the future 📊 Thanks to amazing support from @UTSWHemeOnc, I am pursuing a unique inte….
0
3
0
RT @OncLive: Where is Genitourinary Cancers treatment headed next?.Find out at the #OncLive State of the Science Summit™ with @HHammersMD,….
0
3
0
RT @DrScottHaake: Trying to keep up with all the recent @kidneycancer biomarker developments? Check out our new review for all the latest u….
0
19
0
Our @ASCO update on PARPi+ARPI therapy in BRCA-mut mHRPC: @TiansterZhang . Why diff in combo vs seq crossover in BRCAAway? Small n but fascinating results! Ongoing PARPi combo trials in mHSPC including HARMONY led by @QianJanieQin
1
7
18
RT @paulosiqamaral: Check our manuscript just published at @OncJournal . Clinical & pathological outcomes of pts undergoing consolidative C….
0
11
0
RT @DocMattCampbell: Great Wood fellow case presentations started by @d_shapiro1 at UT Christopher G Wood Austin conference with @JVentoMD….
0
4
0
RT @giulia_claire: 1/7 🚨 Newly published @JAMAOnc! Deep dive into strategies for RCC patients progressing on ICIs 🚨.A comprehensive review….
0
4
0
Officially boarded in Medical Oncology 🧬 and Clinical Informatics 💻! After years of alternating focus between clinical and technical training it’s awesome to now be working at the intersection of these fields. @utswcancer @Parkland @CIC_UTSW @KCPUTSW.
3
2
47
RT @brian_rini: The Vanderbilt GU Program is looking for new faculty members. Clinical investigators with an interest in translational inve….
0
21
0
RT @marklewismd: You've heard of the nine circles of Hell? A patient with cancer documented the TWENTY-SIX steps necessary to get their med….
0
902
0
Excited to start a new role on familiar territory at @utswcancer @Parkland in GU oncology and informatics!. Special thanks to my mentors and peers at @VUMCHemOnc @vumcdbmi for great learning and support throughout my fellowship/master’s.
11
5
94
RT @rmistry91: Speaking of having cool friends, a huge shoutout to @JVentoMD who successfully defended his masters in bioinformatics thesis….
0
4
0
Great life/“tennis” lessons during a season of transitions— even Federer only won 54.1% of points over his career.
This is a MUST WATCH. 😭. Watch highlights from @rogerfederer’s Dartmouth Commencement speech. (via @dartmouth)
0
1
10